Nut Supplementation in Inflammatory Bowel Disease: A Proof-of-Concept Study of Gut Microbiome and Metabolome Effects
A legfontosabb adatok
- Ki végzi
- Sheba Medical Center
- Hol
- Izrael1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Befejeződött
- Résztvevők
- 60 fő vett részt
- Kezdés
- 2025. febr. 27.
- Befejezés
- 2025. szept. 25.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- Mixed Nut Blend
- A regiszteradat frissítve
- 2026. november 17.
Ki vehet részt
- Életkor
- 10 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Részt vehetnek
A regiszter feltételei, szó szerint
Mind a 6 feltétel megnézéseKevesebb
Ki vehet részt
- Patients with Crohn's disease or ulcerative colitis in clinical remission, as determined by the treating physician
- Non-IBD volunteers (controls)
- Willingness and ability to provide written informed consent (and parental/guardian consent for minors)
Ki nem vehet részt
- Active Crohn's disease or ulcerative colitis
- Known nut allergy
- Systemic antibiotic use within 4 weeks preceding enrollment
Hol van ez a vizsgálat?
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
People with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, often continue to experience disruptions in the gut microbiome and metabolism even when their disease is in clinical remission on biologic therapy. These persistent gut-level changes may contribute to disease flares over time.
A teljes eredeti leírásKevesebb
Nuts are nutrient-dense foods rich in unsaturated fats, fiber, minerals, and polyphenols, and have been shown to support gut health in general and cardiometabolic populations. However, their specific effects on the gut microbiome and metabolome in people with IBD in remission have not been examined.
This proof-of-concept study investigated whether short-term, daily consumption of a standardized mixed nut blend (almonds, walnuts, and pecans) shifts the gut microbiome and metabolic signals of people with IBD toward a healthier, control-like profile.
Sixty participants: 21 healthy controls, 19 participants with Crohn's disease in remission, and 20 participants with ulcerative colitis in remission, underwent a 3-day nut-avoidance washout, followed by 10 days of consuming 30 g/day of a mixed nut blend. Fecal samples were collected on days -3, 0, 5, and 10 and analyzed for microbiome composition (16S rRNA sequencing) and metabolite profiles (untargeted LC-MS metabolomics). Participants also completed a food frequency questionnaire and a daily adherence survey.
The study aimed to characterize how a defined, single food item influences gut health signals in IBD remission, providing a foundation for larger, longer-term dietary interventions.
A vizsgálat csoportja
- Mixed Nut SupplementationA vizsgált kezelés
All participants received a defined mixed nut blend consisting of equal weights of raw almonds, walnuts, and pecans (10 g of each per daily portion, 30 g total) for 10 consecutive days, following a 3-day nut-avoidance washout period. Portions were pre-weighed, homogenized, sealed in dedicated single-use bags labeled with the intervention day, and distributed to each participant in a coded box of 10 bags.
Kezelés: Mixed Nut Blend
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Simple Nut Supplementation Induces Positive Gut Metabolic Signals in Patients With Inflammatory Bowel Disease
- A regiszteradat frissítve
- 2026. november 17.